IDH WILDTYPE GLIOBLASTOMA
Clinical trials for IDH WILDTYPE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH WILDTYPE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for IDH WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive brain tumors? drug trial targets recurrent glioblastoma
Disease control Recruiting nowThis early-stage trial tests a new drug called ERAS-801 in 10 adults with a type of aggressive brain cancer (glioblastoma) that has come back or worsened. The drug targets a specific protein (EGFR) found on many of these tumor cells and is designed to reach the brain. The main go…
Matched conditions: IDH WILDTYPE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Brain cancer study asks: is morning or evening chemo better?
Symptom relief Recruiting nowThis study looks at whether taking the chemotherapy drug temozolomide at a specific time of day (morning vs evening) helps people with a type of brain cancer called glioblastoma. About 50 adults who have already had surgery and radiation will be randomly assigned to take their ch…
Matched conditions: IDH WILDTYPE GLIOBLASTOMA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated May 26, 2026 08:19 UTC